Joan T. Merrill, MD, on Optimal Entry Criteria for Lupus Clinical Trials

 

Joan T. Merrill, MD, from the Oklahoma Medical Research Foundation, discusses her research presented at the Annual European Congress of Rheumatology that evaluated different serologic features to encourage more entry in lupus clinical trials of individuals with active disease, and more.

Joan T. Merrill, MD, is director of clinical programs in the Arthritis & Clinical Immunology Research Program at the Oklahoma Medical Research Foundation in Oklahoma City, Oklahoma.

Submit Feedback

Name